A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis

Summary

This is a double-blind, two-period, placebo controlled cross-over Phase IIa study. This study is to use CB2 compound of GW842166 in patients with osteoarthritis. The pain assessments and WOMAC questionnaires will be used in the study after the repeated dose to evaluate the efficacy of CB2 compound of GW842166.

Timeline

Start

2007-07-06

Primary completion

2007-10-09

Completion

2007-10-09

Drugs

Indications